130 related articles for article (PubMed ID: 31740519)
1. Hepatocyte Growth Factor in Blood and Gastric Cancer Risk: A Nested Case-Control Study.
Jang J; Ma SH; Ko KP; Choi BY; Yoo KY; Park SK
Cancer Epidemiol Biomarkers Prev; 2020 Feb; 29(2):470-476. PubMed ID: 31740519
[TBL] [Abstract][Full Text] [Related]
2. Soluble c-Met protein as a susceptible biomarker for gastric cancer risk: A nested case-control study within the Korean Multicenter Cancer Cohort.
Yang JJ; Yang JH; Kim J; Ma SH; Cho LY; Ko KP; Shin A; Choi BY; Kim HJ; Han DS; Eun CS; Song KS; Kim YS; Chang SH; Shin HR; Kang D; Yoo KY; Park SK
Int J Cancer; 2013 May; 132(9):2148-56. PubMed ID: 23001699
[TBL] [Abstract][Full Text] [Related]
3. Serum Helicobacter pylori KatA and AhpC antibodies as novel biomarkers for gastric cancer.
Zhang B; Li HL; Fan Q; Guo F; Ren XY; Zhou HB; Zhu JW; Zhao YS; Tian WJ
World J Gastroenterol; 2016 Jun; 22(21):5060-7. PubMed ID: 27275098
[TBL] [Abstract][Full Text] [Related]
4. Is the association between Helicobacter pylori and gastric cancer confined to CagA-positive strains?
Held M; Engstrand L; Hansson LE; Bergström R; Wadström T; Nyrén O
Helicobacter; 2004 Jun; 9(3):271-7. PubMed ID: 15165264
[TBL] [Abstract][Full Text] [Related]
5. Receiver operating characteristic analysis of prediction for gastric cancer development using serum pepsinogen and Helicobacter pylori antibody tests.
Hamashima C; Sasazuki S; Inoue M; Tsugane S;
BMC Cancer; 2017 Mar; 17(1):183. PubMed ID: 28279154
[TBL] [Abstract][Full Text] [Related]
6. Clinical significance of hepatocyte growth factor/c-Met expression in the assessment of gastric cancer progression.
Noguchi E; Saito N; Kobayashi M; Kameoka S
Mol Med Rep; 2015 May; 11(5):3423-31. PubMed ID: 25592281
[TBL] [Abstract][Full Text] [Related]
7. Opposing risks of gastric cardia and noncardia gastric adenocarcinomas associated with Helicobacter pylori seropositivity.
Kamangar F; Dawsey SM; Blaser MJ; Perez-Perez GI; Pietinen P; Newschaffer CJ; Abnet CC; Albanes D; Virtamo J; Taylor PR
J Natl Cancer Inst; 2006 Oct; 98(20):1445-52. PubMed ID: 17047193
[TBL] [Abstract][Full Text] [Related]
8. Circulating cytokines and gastric cancer risk.
Epplein M; Xiang YB; Cai Q; Peek RM; Li H; Correa P; Gao J; Wu J; Michel A; Pawlita M; Zheng W; Shu XO
Cancer Causes Control; 2013 Dec; 24(12):2245-50. PubMed ID: 24052422
[TBL] [Abstract][Full Text] [Related]
9. MET4 expression predicts poor prognosis of gastric cancers with Helicobacter pylori infection.
Sakamoto N; Tsujimoto H; Takahata R; Cao B; Zhao P; Ito N; Shimazaki H; Ichikura T; Hase K; Vande Woude GF; Shinomiya N
Cancer Sci; 2017 Mar; 108(3):322-330. PubMed ID: 28012218
[TBL] [Abstract][Full Text] [Related]
10. A CagA-independent cluster of antigens related to the risk of noncardia gastric cancer: associations between Helicobacter pylori antibodies and gastric adenocarcinoma explored by multiplex serology.
Song H; Michel A; Nyrén O; Ekström AM; Pawlita M; Ye W
Int J Cancer; 2014 Jun; 134(12):2942-50. PubMed ID: 24259284
[TBL] [Abstract][Full Text] [Related]
11. Helicobacter pylori serological biomarkers of gastric cancer risk in the MCC-Spain case-control Study.
Fernández de Larrea-Baz N; Pérez-Gómez B; Michel A; Romero B; Lope V; Pawlita M; Fernández-Villa T; Moreno V; Martín V; Willhauck-Fleckenstein M; López-Abente G; Castilla J; Fernández-Tardón G; Dierssen-Sotos T; Santibáñez M; Peiró R; Jiménez-Moleón JJ; Navarro C; Castaño-Vinyals G; Kogevinas M; Pollán M; de Sanjosé S; Del Campo R; Waterboer T; Aragonés N
Cancer Epidemiol; 2017 Oct; 50(Pt A):76-84. PubMed ID: 28888185
[TBL] [Abstract][Full Text] [Related]
12. Histology and culture results among subjects with antibodies to CagA but no evidence of Helicobacter pylori infection with IgG ELISA.
Ye W; Held M; Enroth H; Kraaz W; Engstrand L; Nyrén O
Scand J Gastroenterol; 2005 Mar; 40(3):312-8. PubMed ID: 15932172
[TBL] [Abstract][Full Text] [Related]
13. Helicobacter pylori infection and low serum pepsinogen I level as risk factors for gastric carcinoma.
Kokkola A; Louhimo J; Puolakkainen P; Alfthan H; Haglund C; Rautelin H
World J Gastroenterol; 2005 Feb; 11(7):1032-6. PubMed ID: 15742409
[TBL] [Abstract][Full Text] [Related]
14. Serum Helicobacter pylori FliD antibody and the risk of gastric cancer.
Li H; Zhang B; Hu X; Dong Y; Fan Q; Guo F; Ren X; Zhou H; Tian W; Zhao Y
Oncotarget; 2016 Apr; 7(16):22397-408. PubMed ID: 26968951
[TBL] [Abstract][Full Text] [Related]
15. Expression of hepatocyte growth factor, transforming growth factor alpha, apoptosis related proteins Bax and Bcl-2, and gastrin in human gastric cancer.
Konturek PC; Konturek SJ; Sulekova Z; Meixner H; Bielanski W; Starzynska T; Karczewska E; Marlicz K; Stachura J; Hahn EG
Aliment Pharmacol Ther; 2001 Jul; 15(7):989-99. PubMed ID: 11421874
[TBL] [Abstract][Full Text] [Related]
16. Host-pathogen systems biology: logical modelling of hepatocyte growth factor and Helicobacter pylori induced c-Met signal transduction.
Franke R; Müller M; Wundrack N; Gilles ED; Klamt S; Kähne T; Naumann M
BMC Syst Biol; 2008 Jan; 2():4. PubMed ID: 18194572
[TBL] [Abstract][Full Text] [Related]
17. Co-expression of hepatocyte growth factor and c-Met predicts peritoneal dissemination established by autocrine hepatocyte growth factor/c-Met signaling in gastric cancer.
Toiyama Y; Yasuda H; Saigusa S; Matushita K; Fujikawa H; Tanaka K; Mohri Y; Inoue Y; Goel A; Kusunoki M
Int J Cancer; 2012 Jun; 130(12):2912-21. PubMed ID: 21796631
[TBL] [Abstract][Full Text] [Related]
18. Risk for gastric cancer in people with CagA positive or CagA negative Helicobacter pylori infection.
Parsonnet J; Friedman GD; Orentreich N; Vogelman H
Gut; 1997 Mar; 40(3):297-301. PubMed ID: 9135515
[TBL] [Abstract][Full Text] [Related]
19. Role of gastrin in gastric cancerogenesis in Helicobacter pylori infected humans.
Konturek PC; Konturek SJ; Bielanski W; Karczewska E; Pierzchalski P; Duda A; Starzynska T; Marlicz K; Popiela T; Hartwich A; Hahn EG
J Physiol Pharmacol; 1999 Dec; 50(5):857-73. PubMed ID: 10695565
[TBL] [Abstract][Full Text] [Related]
20. Antibodies to CagA protein are associated with gastric atrophy in Helicobacter pylori infection.
Beales IL; Crabtree JE; Scunes D; Covacci A; Calam J
Eur J Gastroenterol Hepatol; 1996 Jul; 8(7):645-9. PubMed ID: 8853252
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
